Evaluation of medication dose alerts in pediatric inpatients

Corinna Scharnweber1, Brandyn D Lau, Nicole Mollenkopf

  • 1Peter L. Reichertz Institute for Medical Informatics University of Braunschweig, Institute of Technology and Hannover Medical School, Germany. corinna.scharnweber@plri.de

Insights

Computerized provider order entry (CPOE) systems generated over 12,000 dose alerts in pediatric medication ordering. Compliance with these alerts was low, particularly for informational alerts, suggesting a need to refine alert systems and clinical practices.

Area of Science:

  • Pediatric pharmacology
  • Health informatics
  • Clinical decision support systems

Background:

  • Computerized provider order entry (CPOE) systems are integral to modern healthcare, aiming to improve medication safety.
  • Dose alerts within CPOE systems are designed to prevent medication errors, but their effectiveness can vary.
  • Understanding the impact and provider compliance with these alerts is crucial for optimizing their design and utility.

Purpose of the Study:

  • To evaluate the impact of 12,093 consecutive dose alerts from a CPOE system on pediatric medication ordering.
  • To analyze the compliance rates for different types of alerts (dose range vs. informational).
  • To inform future development of more effective CPOE alert systems.

Main Methods:

  • Retrospective evaluation of all medication orders and dose alerts at a children's medical and surgical center in 2010.
  • Inclusion of hospitalized patients under 21 years old.
  • Analysis of dose range alerts and informational alerts, including provider compliance rates.

Main Results:

  • Over 182,000 medication orders were analyzed, with 6% generating alerts for over 2000 patients.
  • Dose range alerts constituted 73.4% of all alerts, with an 8.5% compliance rate.
  • Informational alerts comprised 26.6% of alerts, showing a lower compliance rate of 5.5%.

Conclusions:

  • Underdosing alerts appear to offer less value to providers compared to overdosing alerts.
  • Low compliance rates necessitate an evaluation of clinical practice and alert thresholds.
  • Informational alerts regarding dosing guidelines had minimal impact and should be reconsidered in alert system design.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...